Table 4.
Antibiotic susceptibility profiles of PPLAB from koozh
| Antibiotics | Enterococcus sp. | Lactobacillus sp. | ||||||
|---|---|---|---|---|---|---|---|---|
| Sha 1 | Sha 8 | Sha 22 | Sha 24 | Sha 28 | Sha 35 | Sha 7 | Sha 31 | |
| Group I | ||||||||
| Ampicllin | S | S | S | S | S | S | S | S |
| Amoxyclav | S | S | S | S | S | S | S | S |
| Pencillin G | R | R | MS | R | R | R | R | R |
| Cefuroximin | R | R | R | R | MS | R | R | R |
| Cefixime | R | R | R | R | R | R | R | R |
| Vancocmycin | S | R | R | MS | R | R | S | R |
| Bacitracin | R | MS | R | R | R | R | R | R |
| Group II | ||||||||
| Amikacin | R | R | MS | R | R | R | R | R |
| Gentamycin | R | S | MS | R | R | R | R | R |
| Streptomycin | R | R | R | R | R | R | R | R |
| Azithromycin | S | S | S | S | S | S | S | S |
| Erythromycin | R | R | R | R | R | MS | R | MS |
| Chloramphenicol | S | S | S | S | R | S | S | S |
| Tetracycline | S | S | R | S | S | MS | S | S |
| Group III | ||||||||
| Norofloaxicin | MS | R | R | MS | MS | R | R | R |
| Ciprofloaxicin | S | R | R | R | MS | R | S | R |
| Nalidixic acid | R | R | R | R | R | R | R | R |
| Levoflaxicin | S | S | R | MS | R | R | MS | MS |
| Gemoflaxicin | MS | S | MS | R | MS | R | MS | MS |
| Galtifloaxin | MS | MS | MS | R | S | MS | S | MS |
| Overall Resistance % | 45 | 50 | 55 | 60 | 55 | 65 | 50 | 55 |
R resistant, MS moderately susceptible, S susceptible